메뉴 건너뛰기




Volumn 16, Issue 6, 2003, Pages 635-641

Vascular dementia: Changing the paradigm

Author keywords

Alzheimer's disease; Dementia; Donepezil; Executive dysfunction; Galantamine; Lacunar strokes; Memantine; Rivastigmine; Vascular dementia

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CHOLINESTERASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DONEPEZIL; FOLIC ACID; GALANTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; MEMANTINE; NEUROLEPTIC AGENT; NICOTINIC ACID; NITRENDIPINE; NOOTROPIC AGENT; PENTOXIFYLLINE; PERINDOPRIL; RIVASTIGMINE; VASODILATOR AGENT;

EID: 0242490734     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001504-200311000-00006     Document Type: Review
Times cited : (5)

References (82)
  • 1
    • 0036327146 scopus 로고    scopus 로고
    • Vascular dementia revisited: Diagnosis, pathogenesis, treatment and prevention
    • Román GC. Vascular dementia revisited: Diagnosis, pathogenesis, treatment and prevention. Med Clin North Am 2002; 86:479-499. This is a comprehensive and recent review of vascular dementia.
    • (2002) Med Clin North Am , vol.86 , pp. 479-499
    • Román, G.C.1
  • 2
    • 0037262728 scopus 로고    scopus 로고
    • Stroke, cognitive decline and vascular dementia: The silent epidemic of the 21st century
    • Roman GC. Stroke, cognitive decline and vascular dementia: The silent epidemic of the 21st century. Neuroepidemiology 2003; 22:161-164. Vascular dementia may become the most common form of dementia because it affects 30% of ischemic strokes and 26% of patients with congestive heart failure due to hypoperfusion. Also important is the contribution of cerebrovascular disease to Alzheimer's disease.
    • (2003) Neuroepidemiology , vol.22 , pp. 161-164
    • Roman, G.C.1
  • 3
    • 0035195760 scopus 로고    scopus 로고
    • Current concepts in mild cognitive impairment
    • Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58:1985-1992.
    • (2001) Arch Neurol , vol.58 , pp. 1985-1992
    • Petersen, R.C.1    Doody, R.2    Kurz, A.3
  • 4
    • 0026733793 scopus 로고
    • Preventable senility: A call for action against the vascular dementias
    • Hachinski V. Preventable senility: a call for action against the vascular dementias. Lancet 1992; 340:645-648.
    • (1992) Lancet , vol.340 , pp. 645-648
    • Hachinski, V.1
  • 5
    • 0028302251 scopus 로고
    • Vascular dementia: A radical redefinition
    • Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994; 5:130-132.
    • (1994) Dementia , vol.5 , pp. 130-132
    • Hachinski, V.1
  • 6
    • 0038049262 scopus 로고    scopus 로고
    • Vascular cognitive impairment
    • O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003; 2:89-98. This is an important consensus statement and summary of proceedings of a meeting of experts held in Madrid in November, 2001, organized by the International Psychogeriatric Association. Current terminology, classification and clinical forms of vascular cognitive impairment and dementia are reviewed, as well as possible preventive and therapeutic approaches.
    • (2003) Lancet Neurol , vol.2 , pp. 89-98
    • O'Brien, J.T.1    Erkinjuntti, T.2    Reisberg, B.3
  • 9
    • 0033918730 scopus 로고    scopus 로고
    • Inter-rater reliability of the diagnosis of vascular cognitive impairment at a memory clinic
    • Wentzel C, Darvesh S, MacKnight C, et al. Inter-rater reliability of the diagnosis of vascular cognitive impairment at a memory clinic. Neuroepidemiology 2000; 19:186-193.
    • (2000) Neuroepidemiology , vol.19 , pp. 186-193
    • Wentzel, C.1    Darvesh, S.2    MacKnight, C.3
  • 10
    • 0036330348 scopus 로고    scopus 로고
    • Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia
    • Ingles JL, Wentzel C, Fisk JD, Rockwood K. Neuropsychological predictors of incident dementia in patients with vascular cognitive impairment, without dementia. Stroke 2002; 33:1999-2002.
    • (2002) Stroke , vol.33 , pp. 1999-2002
    • Ingles, J.L.1    Wentzel, C.2    Fisk, J.D.3    Rockwood, K.4
  • 11
    • 0037266244 scopus 로고    scopus 로고
    • Five-year outcomes for dementia defined solely by neuropsychological test performance
    • Ingles JL, Fisk JD, Merry HR, Rockwood K. Five-year outcomes for dementia defined solely by neuropsychological test performance. Neuroepidemiology 2003; 22:172-178. Objective neuropsychological tests appear to identify with significant degree of certainty individuals without cognitive impairment, those with dementia, and those with cognitive impairment short of dementia.
    • (2003) Neuroepidemiology , vol.22 , pp. 172-178
    • Ingles, J.L.1    Fisk, J.D.2    Merry, H.R.3    Rockwood, K.4
  • 15
    • 0037111458 scopus 로고    scopus 로고
    • Vascular dementia
    • Proceedings of the 2nd International Congress on Vascular Dementia
    • Korczyn AD, Roman GC, Bornstein NM, editors. Vascular dementia. Proceedings of the 2nd International Congress on Vascular Dementia. New York: J Neurol Sci 2002; 203-204:1-298.
    • (2002) New York: J Neurol Sci , vol.203-204 , pp. 1-298
    • Korczyn, A.D.1    Roman, G.C.2    Bornstein, N.M.3
  • 16
    • 0242650941 scopus 로고    scopus 로고
    • Converging pathogenic mechanisms in vascular and degenerative dementia
    • Iadecola C, Gorelick PB. Converging pathogenic mechanisms in vascular and degenerative dementia. Stroke 2002; 33:1152-1162. This is a recent review of the vascular mechanisms common to both stroke and Alzheimer's disease.
    • (2002) Stroke , vol.33 , pp. 1152-1162
    • Iadecola, C.1    Gorelick, P.B.2
  • 17
    • 0037078312 scopus 로고    scopus 로고
    • The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) study
    • Forette F, Seux ML, Staessen JA, et al. for the Systolic Hypertension in Europe Investigators: The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med 2002; 162;2046-2052. Treatment of isolated systolic hypertension in the elderly with the calcium-channel blocker nitrendipine resulted in lower incidence of stroke and 50% reduction in the incidence of dementia, including Alzheimer's disease.
    • (2002) Arch Intern Med , vol.162 , pp. 2046-2052
    • Forette, F.1    Seux, M.L.2    Staessen, J.A.3
  • 18
    • 0036126850 scopus 로고    scopus 로고
    • Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people
    • Rockwood K, Kirkland S, Hogan DB, et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch Neurol 2002; 59:223-227. This and other epidemiological studies reviewed here show that the use of statins appears to decrease the incidence of Alzheimer's disease.
    • (2002) Arch Neurol , vol.59 , pp. 223-227
    • Rockwood, K.1    Kirkland, S.2    Hogan, D.B.3
  • 19
    • 0037387057 scopus 로고    scopus 로고
    • Vascular dementia in a population-based autopsy study
    • Knopman DS, Parisi JE, Boeve BF, et al. Vascular dementia in a population-based autopsy study. Arch Neurol 2003; 60:569-675. In this population-based autopsy study using the medical records-linkage system of the Rochester Epidemiology Project, vascular lesions causing dementia were commonly identified in the absence of major Alzheimer's disease pathological findings.
    • (2003) Arch Neurol , vol.60 , pp. 569-675
    • Knopman, D.S.1    Parisi, J.E.2    Boeve, B.F.3
  • 20
    • 18744366040 scopus 로고    scopus 로고
    • Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants
    • White L, Petrovitch H, Hardman J, et al. Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann NY Acad Sci 2002; 977:9-23. This is an important cohort study demonstrating the elevated frequency of vascular lesions in elderly patients with dementia.
    • (2002) Ann NY Acad Sci , vol.977 , pp. 9-23
    • White, L.1    Petrovitch, H.2    Hardman, J.3
  • 21
    • 0036459947 scopus 로고    scopus 로고
    • Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology
    • Zekry D, Duyckaerts C, Belmin J, et al. Alzheimer's disease and brain infarcts in the elderly. Agreement with neuropathology. J Neurol 2002; 249:1529-1534.
    • (2002) J Neurol , vol.249 , pp. 1529-1534
    • Zekry, D.1    Duyckaerts, C.2    Belmin, J.3
  • 22
    • 0036142037 scopus 로고    scopus 로고
    • Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study
    • ILSA Working Group
    • Di Carlo A, Baldereschi M, Amaducci L, et al. ILSA Working Group. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc 2002; 50:41-48.
    • (2002) J Am Geriatr Soc , vol.50 , pp. 41-48
    • Di Carlo, A.1    Baldereschi, M.2    Amaducci, L.3
  • 23
    • 0036792775 scopus 로고    scopus 로고
    • Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn
    • Edland SD, Rocca WA, Petersen RC, et al. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol 2002; 59:1589-1593.
    • (2002) Arch Neurol , vol.59 , pp. 1589-1593
    • Edland, S.D.1    Rocca, W.A.2    Petersen, R.C.3
  • 24
    • 0036790760 scopus 로고    scopus 로고
    • Incidence of vascular dementia in Rochester, Minn, 1985-1989
    • Knopman DS, Rocca WA, Cha RH, et al. Incidence of vascular dementia in Rochester, Minn, 1985-1989. Arch Neurol 2002; 59:1605-1610.
    • (2002) Arch Neurol , vol.59 , pp. 1605-1610
    • Knopman, D.S.1    Rocca, W.A.2    Cha, R.H.3
  • 25
    • 0037111120 scopus 로고    scopus 로고
    • Vascular dementia may be the most common form of dementia in the elderly
    • Román GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002; 203-204:7-10.
    • (2002) J Neurol Sci , vol.203-204 , pp. 7-10
    • Román, G.C.1
  • 26
    • 0037385097 scopus 로고    scopus 로고
    • Emotions, mood, and behavior after stroke
    • Bogousslavsky J. Emotions, mood, and behavior after stroke. Stroke 2003; 34:1046-1050. Cognitive decline, post-stroke depression, and post-stroke fatigue may occur as a result of disruption of cortico-subcortical circuits.
    • (2003) Stroke , vol.34 , pp. 1046-1050
    • Bogousslavsky, J.1
  • 27
    • 0038049283 scopus 로고    scopus 로고
    • Subcortical ischaemic vascular dementia
    • Román GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol 2002; 1:426-436. This paper provides current views of the pathophysiology of the subcortical form of vascular dementia resulting from small-vessel disease. The main mechanisms are obstruction leading to lacunar strokes, and hypoperfusion resulting in incomplete white matter ischemia and Binswanger's disease. The prevalence, clinical manifestations, and potential forms of treatment are also reviewed.
    • (2002) Lancet Neurol , vol.1 , pp. 426-436
    • Román, G.C.1    Erkinjuntti, T.2    Wallin, A.3
  • 28
    • 0042970156 scopus 로고    scopus 로고
    • Long-term prognosis after lacunar infarction
    • Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol 2003; 2:238-245. This excellent review demonstrates that mortality in patients with symptomatic lacunes increases to 27.4% at 5 years and 60% after 10 years. Most deaths (52%) are cardiovascular and 20% from stroke. Older age, diabetes, smoking, high disability score, male gender, non-use of aspirin, multiple asymptomatic lacunes and leukoaraiosis had worse prognosis.
    • (2003) Lancet Neurol , vol.2 , pp. 238-245
    • Norrving, B.1
  • 29
    • 0037468674 scopus 로고    scopus 로고
    • Silent brain infarcts and the risk of dementia and cogntive decline
    • Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cogntive decline. N Engl J Med 2003; 348:1215-1222. This study from the Rotterdam cohort demonstrated that silent, subcortical lacunar strokes, particularly in the thalamus, produced significant cognitive decline and more than doubled the risk of dementia (hazard ratio, 2.26; 95% CI, 1.09-4.70).
    • (2003) N Engl J Med , vol.348 , pp. 1215-1222
    • Vermeer, S.E.1    Prins, N.D.2    Den Heijer, T.3
  • 30
    • 0037338557 scopus 로고    scopus 로고
    • Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?
    • Wardlaw JM, Sandercokc PAG, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34:806-812. The authors postulate that damage of the endothelium of cerebral small-vessels may allow leakage of plasma components into the vessels and surrounding brain tissue leading to neuronal damage, lacunes, white matter lesions, and eventual dementia.
    • (2003) Stroke , vol.34 , pp. 806-812
    • Wardlaw, J.M.1    Sandercokc, P.A.G.2    Dennis, M.S.3    Starr, J.4
  • 31
    • 0038076409 scopus 로고    scopus 로고
    • Vascular dementia: Distinguishing characteristics, treatment, and prevention
    • Román GC. Vascular dementia: Distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 2003; 51:S296-S304. This is an updated review on the characteristic features of vascular dementia, differential diagnosis, treatment and prevention.
    • (2003) J Am Geriatr Soc , vol.51
    • Román, G.C.1
  • 32
    • 0027534657 scopus 로고
    • Vascular dementia: Diagnostic criteria for research studies
    • Report of the NINDS-AIREN International Workshop
    • Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260.
    • (1993) Neurology , vol.43 , pp. 250-260
    • Román, G.C.1    Tatemichi, T.K.2    Erkinjuntti, T.3
  • 33
    • 0036969639 scopus 로고    scopus 로고
    • Defining dementia: Clinical criteria for the diagnosis of vascular dementia
    • Román GC. Defining dementia: Clinical criteria for the diagnosis of vascular dementia. Acta Neurol Scand 2002; 106 (Suppl 178):1-4.
    • (2002) Acta Neurol Scand , vol.106 , Issue.178 SUPPL. , pp. 1-4
    • Román, G.C.1
  • 36
    • 0033202044 scopus 로고    scopus 로고
    • Executive control function: A rational basis for the diagnosis of vascular dementia
    • Román GC, Royall DR. Executive control function: A rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord 1999; 13 (Suppl 3):69-80.
    • (1999) Alzheimer Dis Assoc Disord , vol.13 , Issue.3 SUPPL. , pp. 69-80
    • Román, G.C.1    Royall, D.R.2
  • 37
    • 0033546910 scopus 로고    scopus 로고
    • Differentiation of vascular dementia from Alzheimer disease on neuropsychological tests
    • Looi JC, Sachdev PS. Differentiation of vascular dementia from Alzheimer disease on neuropsychological tests. Neurology 1999; 53:670-678.
    • (1999) Neurology , vol.53 , pp. 670-678
    • Looi, J.C.1    Sachdev, P.S.2
  • 38
    • 0033773223 scopus 로고    scopus 로고
    • Executive cognitive impairment: A novel perspective on dementia
    • Royall DR. Executive cognitive impairment: A novel perspective on dementia. Neuroepidemiology 2000; 19:293-299.
    • (2000) Neuroepidemiology , vol.19 , pp. 293-299
    • Royall, D.R.1
  • 39
    • 0036754864 scopus 로고    scopus 로고
    • Executive control function: A review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association
    • Royall DR, Lauterbach EC, Cummings JL, et al. Executive control function: A review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002; 14:377-405. This is a state of the art and comprehensive review (343 references) of executive function by a group of experts from the American Neuropsychiatric Association.
    • (2002) J Neuropsychiatry Clin Neurosci , vol.14 , pp. 377-405
    • Royall, D.R.1    Lauterbach, E.C.2    Cummings, J.L.3
  • 40
    • 0031837523 scopus 로고    scopus 로고
    • Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study
    • Grigsby J, Kaye K, Baxter J, Shetterly SM, Hamman RF. Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J Am Geriatr Soc 1998; 46:590-596.
    • (1998) J Am Geriatr Soc , vol.46 , pp. 590-596
    • Grigsby, J.1    Kaye, K.2    Baxter, J.3    Shetterly, S.M.4    Hamman, R.F.5
  • 41
    • 0036040493 scopus 로고    scopus 로고
    • Prevalence of disorders of executive cognitive functioning among the elderly: Findings from the San Luis Valley Health and Aging Study
    • Grigsby J, Kaye K, Shetterly SM, et al. Prevalence of disorders of executive cognitive functioning among the elderly: Findings from the San Luis Valley Health and Aging Study. Neuroepidemiology 2002; 21:213-220.
    • (2002) Neuroepidemiology , vol.21 , pp. 213-220
    • Grigsby, J.1    Kaye, K.2    Shetterly, S.M.3
  • 42
    • 0033837366 scopus 로고    scopus 로고
    • Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals
    • Cahn-Weiner DA, Malloy PF, Boyle PA, et al. Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals. Clin Neuropsychol 2000; 14:187-195.
    • (2000) Clin Neuropsychol , vol.14 , pp. 187-195
    • Cahn-Weiner, D.A.1    Malloy, P.F.2    Boyle, P.A.3
  • 43
    • 0036742934 scopus 로고    scopus 로고
    • Standard measures of executive function in predicting instrumental activities of daily living in older adults
    • Bell-McGinty S, Podell K, Franzen M, et al. Standard measures of executive function in predicting instrumental activities of daily living in older adults. Int J Geriatr Psychiatry 2002; 17:828-834.
    • (2002) Int J Geriatr Psychiatry , vol.17 , pp. 828-834
    • Bell-McGinty, S.1    Podell, K.2    Franzen, M.3
  • 44
    • 0038811744 scopus 로고    scopus 로고
    • Re: Bell-McGinty et al standard measures of executive function in predicting instrumental activities of daily living in older adults
    • Barberger-Gateau P, Fabrigoule C. Re: Bell-McGinty et al standard measures of executive function in predicting instrumental activities of daily living in older adults. Int J Geriatr Psychiatry 2003; 18:459-460.
    • (2003) Int J Geriatr Psychiatry , vol.18 , pp. 459-460
    • Barberger-Gateau, P.1    Fabrigoule, C.2
  • 45
    • 0036161540 scopus 로고    scopus 로고
    • Cognitive and motor impairments predict functional declines in patients with vascular dementia
    • Boyle PA, Cohen RA, Paul R, et al. Cognitive and motor impairments predict functional declines in patients with vascular dementia. Int J Geriatr Psychiatry 2002; 17:164-169.
    • (2002) Int J Geriatr Psychiatry , vol.17 , pp. 164-169
    • Boyle, P.A.1    Cohen, R.A.2    Paul, R.3
  • 46
    • 0036126187 scopus 로고    scopus 로고
    • The global deterioration scale: Relationships to neuropsychological performance and activities of daily living in patients with vascular dementia
    • Paul RH, Cohen RA, Moser DJ, et al. The global deterioration scale: relationships to neuropsychological performance and activities of daily living in patients with vascular dementia. J Geriatr Psychiatry Neurol 2002; 15:50-54.
    • (2002) J Geriatr Psychiatry Neurol , vol.15 , pp. 50-54
    • Paul, R.H.1    Cohen, R.A.2    Moser, D.J.3
  • 47
    • 0036321355 scopus 로고    scopus 로고
    • Behavioral problems as predictors of functional abilities of vascular dementia patients
    • Zawacki TM, Grace J, Paul R, et al. Behavioral problems as predictors of functional abilities of vascular dementia patients. J Neuropsychiatry Clin Neurosci 2002; 14:296-302.
    • (2002) J Neuropsychiatry Clin Neurosci , vol.14 , pp. 296-302
    • Zawacki, T.M.1    Grace, J.2    Paul, R.3
  • 48
    • 18744384929 scopus 로고    scopus 로고
    • Subcortical vascular disease and functional decline: A 6-year predictor study
    • Bennett HP, Corbett AJ, Gaden S, et al. Subcortical vascular disease and functional decline: a 6-year predictor study. J Am Geriatr Soc 2002; 50:1969-1977.
    • (2002) J Am Geriatr Soc , vol.50 , pp. 1969-1977
    • Bennett, H.P.1    Corbett, A.J.2    Gaden, S.3
  • 49
    • 0037233902 scopus 로고    scopus 로고
    • Cognitive and neurologic predictors of functional impairment in vascular dementia
    • Boyle PA, Paul R, Moser D, et al. Cognitive and neurologic predictors of functional impairment in vascular dementia. Am J Geriatr Psychiatry 2003; 11:103-106. The main predictor of functional impairment in IADLs was poor performance on the initiation-perseverance scale (28% of the variance); white matter lesions with presence of subcortical hyperintensities in magnetic resonance imaging accounted for another 14%.
    • (2003) Am J Geriatr Psychiatry , vol.11 , pp. 103-106
    • Boyle, P.A.1    Paul, R.2    Moser, D.3
  • 50
    • 0037371473 scopus 로고    scopus 로고
    • Executive dysfunction and apathy predict functional impairment in Alzheimer disease
    • Boyle PA, Malloy PF, Salloway S, et al. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am J Geriatr Psychiatry 2003; 11:214-221. Executive dysfunction and frontal-behavior impairment explained 28% of the variance in basic ADLs. Apathy alone explained 17% of the variance. Frontal involvement is a late phase of AD, or may result from lacunes or white matter involvement.
    • (2003) Am J Geriatr Psychiatry , vol.11 , pp. 214-221
    • Boyle, P.A.1    Malloy, P.F.2    Salloway, S.3
  • 51
    • 0031741709 scopus 로고    scopus 로고
    • Executive dyscontrol: An important factor affecting the level of care received by older retirees
    • Royall DR, Cabello M, Polk MJ. Executive dyscontrol: an important factor affecting the level of care received by older retirees. J Am Geriatr Soc 1998; 46:1519-1524.
    • (1998) J Am Geriatr Soc , vol.46 , pp. 1519-1524
    • Royall, D.R.1    Cabello, M.2    Polk, M.J.3
  • 52
    • 0034538141 scopus 로고    scopus 로고
    • Correlates of disability among elderly retirees with 'subclinical' cognitive impairment
    • Royall DR, Chiodo LK, Polk MJ. Correlates of disability among elderly retirees with 'subclinical' cognitive impairment. J Gerontol A Biol Sci Med Sci 2000; 55A:M541-M546.
    • (2000) J Gerontol A Biol Sci Med Sci , vol.55 A
    • Royall, D.R.1    Chiodo, L.K.2    Polk, M.J.3
  • 53
    • 0036142074 scopus 로고    scopus 로고
    • Clinical presentation of the 'depression-executive dysfunction syndrome' of late life
    • Alexopoulos GS, Kiosses DN, Klimstra S, et al. Clinical presentation of the 'depression-executive dysfunction syndrome' of late life. Am J Geriatr Psychiatry 2002; 10:98-106.
    • (2002) Am J Geriatr Psychiatry , vol.10 , pp. 98-106
    • Alexopoulos, G.S.1    Kiosses, D.N.2    Klimstra, S.3
  • 54
    • 0036226876 scopus 로고    scopus 로고
    • The microvascular frontal-subcortical syndrome of aging
    • Pugh KG, Lipsitz LA. The microvascular frontal-subcortical syndrome of aging. Neurobiol Aging 2002; 23:421-431.
    • (2002) Neurobiol Aging , vol.23 , pp. 421-431
    • Pugh, K.G.1    Lipsitz, L.A.2
  • 55
    • 0036042853 scopus 로고    scopus 로고
    • Post-stroke depression, executive dysfunction and functional outcome
    • Pohjasvaara T, Leskela M, Vataja R, et al. Post-stroke depression, executive dysfunction and functional outcome. Eur J Neurol 2002; 9:269-275.
    • (2002) Eur J Neurol , vol.9 , pp. 269-275
    • Pohjasvaara, T.1    Leskela, M.2    Vataja, R.3
  • 56
    • 0032930434 scopus 로고    scopus 로고
    • Neurological correlates of depressive symptoms in Alzheimer's disease and vascular dementia
    • Simpson S, Allen H, Tomenson B, Burns A. Neurological correlates of depressive symptoms in Alzheimer's disease and vascular dementia. J Affect Disord 1999; 53:129-136.
    • (1999) J Affect Disord , vol.53 , pp. 129-136
    • Simpson, S.1    Allen, H.2    Tomenson, B.3    Burns, A.4
  • 57
    • 0036059134 scopus 로고    scopus 로고
    • Relationship between depressive symptomatology and the subcortical brain syndrome in dementia
    • Lind K, Edman A, Karlsson I, et al. Relationship between depressive symptomatology and the subcortical brain syndrome in dementia. Int J Geriatr Psychiatry 2002; 17:774-778.
    • (2002) Int J Geriatr Psychiatry , vol.17 , pp. 774-778
    • Lind, K.1    Edman, A.2    Karlsson, I.3
  • 58
    • 0037346617 scopus 로고    scopus 로고
    • Ischemic stroke and depression
    • Desmond DW, Remien RH, Moroney JT, et al. Ischemic stroke and depression. J Int Neuropsychol Soc 2003; 9:429-439. Post-stroke depression was associated with more severe strokes, particularly affecting limbic structures.
    • (2003) J Int Neuropsychol Soc , vol.9 , pp. 429-439
    • Desmond, D.W.1    Remien, R.H.2    Moroney, J.T.3
  • 59
    • 0037227914 scopus 로고    scopus 로고
    • Poststroke depression: An 18-month follow-up
    • Berg A, Palomaki H, Lehtihalmes M, et al. Poststroke depression: an 18-month follow-up. Stroke 2003; 34:138-143. Half of the patients had at least mild depressive symptoms post-stroke, and almost half of those with post-stroke depression had persistent symptoms up to 18 months later.
    • (2003) Stroke , vol.34 , pp. 138-143
    • Berg, A.1    Palomaki, H.2    Lehtihalmes, M.3
  • 60
    • 0037547119 scopus 로고    scopus 로고
    • A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction
    • Aben I, Verhey F, Strik J, et al. A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J Neurol Neurosurg Psychiatry 2003; 74:581-585. In this study, the incidence of major and minor depression was similar in patients with first-ever stroke or myocardial infarction suggesting that a particular mechanism linked to stroke damage may fail to explain the occurrence of depression.
    • (2003) J Neurol Neurosurg Psychiatry , vol.74 , pp. 581-585
    • Aben, I.1    Verhey, F.2    Strik, J.3
  • 61
    • 0037191726 scopus 로고    scopus 로고
    • Abnormality of gait as a predictor of non-Alzheimer's dementia
    • Verghese J, Lipton RB, Hall CB, et al. Abnormality of gait as a predictor of non-Alzheimer's dementia. N Engl J Med 2002; 347:1761-1768. Abnormal gait is usually found in non-Alzheimer's disease dementias.
    • (2002) N Engl J Med , vol.347 , pp. 1761-1768
    • Verghese, J.1    Lipton, R.B.2    Hall, C.B.3
  • 62
    • 0242482630 scopus 로고    scopus 로고
    • Abnormal gait and non-Alzheimer dementia
    • Verghese J. Abnormal gait and non-Alzheimer dementia. Biomed Pharmacother 2003; 57:109.
    • (2003) Biomed Pharmacother , vol.57 , pp. 109
    • Verghese, J.1
  • 63
    • 0002639298 scopus 로고    scopus 로고
    • Results of clinical studies with donepezil in vascular dementia
    • Pratt RD, Perdomo CA. Results of clinical studies with donepezil in vascular dementia. Am J Geriatr Psychiatry 2002; 10 (Suppl 1):88-89.
    • (2002) Am J Geriatr Psychiatry , vol.10 , Issue.1 SUPPL. , pp. 88-89
    • Pratt, R.D.1    Perdomo, C.A.2
  • 64
    • 0038387609 scopus 로고    scopus 로고
    • Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial
    • in press
    • Black S, Román G, Geldmacher DS, et al. Efficacy and tolerability of donepezil in vascular dementia: Positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke (in press).
    • Stroke
    • Black, S.1    Román, G.2    Geldmacher, D.S.3
  • 65
    • 0042432057 scopus 로고    scopus 로고
    • Donepezil in vascular dementia: A randomized, placebo-controlled study
    • Wilkinson D, Doody R, Helme R, et al. Donepezil in vascular dementia: A randomized, placebo-controlled study. Neurology 2003; 61:479-486. Published results of a large controlled trial demonstrating efficacy of donepezil in cognition, activities of daily living and global function in patients with vascular dementia compared with placebo; despite numerous medications the drug was relatively well tolerated.
    • (2003) Neurology , vol.61 , pp. 479-486
    • Wilkinson, D.1    Doody, R.2    Helme, R.3
  • 66
    • 0037111266 scopus 로고    scopus 로고
    • Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia
    • Pratt RD. Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia. J Neurol Sci 2002; 203-204:57-65.
    • (2002) J Neurol Sci , vol.203-204 , pp. 57-65
    • Pratt, R.D.1
  • 67
    • 0242482631 scopus 로고    scopus 로고
    • Donepezil-treated patients demonstrate global benefits on the Clinician's Interview-based Impression of Change-plus version: A comparison of Alzheimer's disease versus vascular dementia
    • Doody RS, Pratt RD, Perdomo CE, et al. Donepezil-treated patients demonstrate global benefits on the Clinician's Interview-based Impression of Change-plus version: A comparison of Alzheimer's disease versus vascular dementia [abstract]. Neurology 2003; 60 (Suppl 1):A412.
    • (2003) Neurology , vol.60 , Issue.1 SUPPL.
    • Doody, R.S.1    Pratt, R.D.2    Perdomo, C.E.3
  • 68
    • 0037070773 scopus 로고    scopus 로고
    • Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: A randomized trial
    • Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Lancet 2002; 359:1283-1290. In this controlled clinical trial the cholinergic agent galantamine demonstrated efficacy on cognition, activities of daily living and behaviour in patients with Alzheimer's disease complicated with stroke and in a smaller group of patients with vascular dementia; galantamine was well tolerated.
    • (2002) Lancet , vol.359 , pp. 1283-1290
    • Erkinjuntti, T.1    Kurz, A.2    Gauthier, S.3
  • 69
    • 0034963186 scopus 로고    scopus 로고
    • Rivastigmine in subcortical vascular dementia: A comparison trial on efficacy and tolerability for 12 months follow-up
    • Moretti R, Torre P, Antonello RM, Cazzato G. Rivastigmine in subcortical vascular dementia: a comparison trial on efficacy and tolerability for 12 months follow-up. Eur J Neurol 2001; 8:361-362.
    • (2001) Eur J Neurol , vol.8 , pp. 361-362
    • Moretti, R.1    Torre, P.2    Antonello, R.M.3    Cazzato, G.4
  • 70
    • 0037111361 scopus 로고    scopus 로고
    • Rivastigmine in subcortical vascular dementia. An open 22-month study
    • Moretti R, Torre P, Antonello RM, et al. Rivastigmine in subcortical vascular dementia. An open 22-month study. J Neurol Sci 2002; 203-204:141-146.
    • (2002) J Neurol Sci , vol.203-204 , pp. 141-146
    • Moretti, R.1    Torre, P.2    Antonello, R.M.3
  • 71
    • 0036314492 scopus 로고    scopus 로고
    • Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized, placebo-controlled trial (MMM 300)
    • Orgogozo J-M, Rigaud A-S, Stöffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 2002; 33:1834-1839. Memantine therapy resulted in stabilzation of patients with vascular dementia, compared with placebo controls; this is the first controlled clinical trial of memantine in vascular dementia.
    • (2002) Stroke , vol.33 , pp. 1834-1839
    • Orgogozo, J.-M.1    Rigaud, A.-S.2    Stöffler, A.3
  • 72
    • 0036840767 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)
    • Wilcock G, Möbius HJ, Stoffler A, for the MMM 500 Group. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol 2002; 17:297-305. Results of this trial of memantine in patients with vascular dementia were similar to those of the previous study.
    • (2002) Int Clin Psychopharmacol , vol.17 , pp. 297-305
    • Wilcock, G.1    Möbius, H.J.2    Stoffler, A.3
  • 73
    • 0037078284 scopus 로고    scopus 로고
    • Preservation of cognitive function with antihypertensive medications: A longitudinal analysis of a community-based sample of African Americans
    • Murray MD, Lane KA, Gao S, et al. Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. Arch Intern Med 2002; 162:2046-2052. Treatment of blood pressure resulted in prevention of dementia in this high-risk group.
    • (2002) Arch Intern Med , vol.162 , pp. 2046-2052
    • Murray, M.D.1    Lane, K.A.2    Gao, S.3
  • 74
    • 0035968623 scopus 로고    scopus 로고
    • Randomized trial of perindopril-based blood pressure lowering regimen among 6105 individuals with prior stroke or transient ischemic attack
    • PROGRESS Collaborative Group. Randomized trial of perindopril-based blood pressure lowering regimen among 6105 individuals with prior stroke or transient ischemic attack. Lancet 2001; 358:1033-1041.
    • (2001) Lancet , vol.358 , pp. 1033-1041
  • 75
    • 0038669268 scopus 로고    scopus 로고
    • Effects of blood pressure lowering with perindopril and indapamide therapy in dementia and cognitive decline in patients with cerebrovascular disease
    • Tzourio C, Andersen C, Chapman N, et al. for the PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy in dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163:1069-1075. During follow-up dementia occurred in 6.3% of the treated group and 7.1% of the placebo group for a relative risk reduction of 12%. A 19% risk reduction of cognitive decline was also documented in the active treatment group.
    • (2003) Arch Intern Med , vol.163 , pp. 1069-1075
    • Tzourio, C.1    Andersen, C.2    Chapman, N.3
  • 76
    • 0037075257 scopus 로고    scopus 로고
    • Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
    • Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483.
    • (2002) N Engl J Med , vol.346 , pp. 476-483
    • Seshadri, S.1    Beiser, A.2    Selhub, J.3
  • 77
    • 0037226674 scopus 로고    scopus 로고
    • Homocysteine and brain atrophy on MRI of non-demented elderly
    • den Heijer T, Vermeer SE, Clarke R, et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 2003; 126:170-175. Increase in levels of homocysteine correlate with brain atrophy in non-demented elderly subjects.
    • (2003) Brain , vol.126 , pp. 170-175
    • Den Heijer, T.1    Vermeer, S.E.2    Clarke, R.3
  • 78
    • 0034068273 scopus 로고    scopus 로고
    • Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: Findings from the Nun study
    • Snowdon DA, Tully CL, Smith CD, et al. Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr 2000; 71:993-998.
    • (2000) Am J Clin Nutr , vol.71 , pp. 993-998
    • Snowdon, D.A.1    Tully, C.L.2    Smith, C.D.3
  • 79
    • 0037635069 scopus 로고    scopus 로고
    • The Mediterranean diet and mortality: Olive oil and beyond
    • Hu FB. The Mediterranean diet and mortality: olive oil and beyond. N Engl J Med 2003; 348:2595-2596.
    • (2003) N Engl J Med , vol.348 , pp. 2595-2596
    • Hu, F.B.1
  • 80
    • 0038310626 scopus 로고    scopus 로고
    • Adherence to a Mediterranean diet and survival in a Greek population
    • Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348:2599-2608. The effects of a Mediterranean diet in preventing cardiovascular ischemic disease and stroke are well known.
    • (2003) N Engl J Med , vol.348 , pp. 2599-2608
    • Trichopoulou, A.1    Costacou, T.2    Bamia, C.3    Trichopoulos, D.4
  • 81
    • 0038130715 scopus 로고    scopus 로고
    • Leisure activities and the risk of dementia in the elderly
    • Verghese J, Lipton RB, Katz MJ, et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003; 348:2508-2516. Participation in cognitively demanding leisure activities in the elderly appears to protect against dementia. Activities include playing board games such as chess, checkers, backgammon, cards, reading, and playing a musical instrument.
    • (2003) N Engl J Med , vol.348 , pp. 2508-2516
    • Verghese, J.1    Lipton, R.B.2    Katz, M.J.3
  • 82
    • 0038130760 scopus 로고    scopus 로고
    • Use it or lose it: Do effortful mental activities protect against dementia?
    • Coyle JT. Use it or lose it: Do effortful mental activities protect against dementia? N Engl J Med 2003; 348:2489-2490. In the accompanying editorial, the theory of 'cognitive reserve' is mentioned as a likely explanation.
    • (2003) N Engl J Med , vol.348 , pp. 2489-2490
    • Coyle, J.T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.